Popular biopharmaceutical company Pfizer (PFE) plans to cut around 330 jobs at its Catania plant in Sicily. This is part of a ...

Johnson & Johnson trades at a higher valuation with growing sales, while Pfizer's dividend yield is near 6% as patents expire from 2026 through 2030.

Many dividend investors may be overlooking Pfizer's stock, and that could be a costly mistake.

Pfizer's dividend yield has climbed well above what most blue-chip drugmakers offer, and the reason behind that gap matters ...

Pfizer (PFE) stock has returned 17.5% over the past three months, easily outpacing the 3.7% return for the S&P 500. The board ...

The AI Change That Let Pfizer’s Albert Bourla Sleep Better ...

Pfizer's yield towers over Johnson and Johnson's, but a bigger number on paper can hide serious risks underneath. Before you ...

Pfizer's rebound is well underway.

Pfizer Inc. (NYSE:PFE) has barely rewarded shareholders over the past year. That underperformance has left Pfizer looking ...

Pfizer faces some major LoE headwinds, but the stock is cheap and offers a large dividend, offering a solid total return potential. Click to read more on PFE.

Pfizer ( PFE) plans to cut around 330 jobs at its Catania plant in Sicily as part of a restructuring that includes the ...

The HER2CLIMB-05 trial is a randomized, double blind, placebo-controlled, pivotal Phase 3 study evaluating the efficacy and safety of TUKYSA compared to placebo, both in combination with trastuzumab ...